Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04000971 · ClinicalTrials.gov registry record · NA

Coordinated, Collaborative, Comprehensive, Family-based, Integrated, Technology-enabled Stroke Care

A NA study, sponsored by Vanderbilt University Medical Center.

Completed
Registry status
NA
Development phase
1,196
Enrollment target

NCT04000971 is a NA study that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 1,196 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04000971, a NA study, has completed, sponsored by Vanderbilt University Medical Center.

COMPLETED
Registry status
NA
Development phase
1,196 participants
Enrollment target

Study Summary

Stroke is the 5th leading cause of death and the leading cause of adult disability in the United States (US). Stroke is a complex disease with multiple interacting risk factors (including genetic, high blood pressure and cholesterol, and lifestyle factors like smoking, diet, and exercise) that lead to initial and recurrent stroke. Up to 90% of stroke survivors have some functional deficit that impacts both physical and mental health.

Interventions

  • OTHER Integrated Stroke Practice Unit
  • OTHER Comprehensive or Primary Stroke Center

Trial Details

FieldValue
Enrollment Target 1,196 participants
Start Date 2020-02-25
Est. Completion 2024-09-30
Phase NA

What the Registry Record Tells You About NCT04000971

The ClinicalTrials.gov registry entry for NCT04000971 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,196 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Integrated Stroke Practice Unit is the first listed.

NCT04000971 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04000971 about?

NCT04000971 is a clinical study titled "Coordinated, Collaborative, Comprehensive, Family-based, Integrated, Technology-enabled Stroke Care". Stroke is the 5th leading cause of death and the leading cause of adult disability in the United States (US). Stroke is a complex disease with multiple interacting risk factors (including genetic, high blood pressure and cholesterol, and lifestyle factors like smoking, diet, and exercise) that lead ...

What is the current status of trial NCT04000971?

This trial is currently completed. It is a NA study. The enrollment target is 1,196 participants. The study started on 2020-02-25. Estimated completion is 2024-09-30.

What interventions are being tested in trial NCT04000971?

The interventions under investigation include: Integrated Stroke Practice Unit (OTHER), Comprehensive or Primary Stroke Center (OTHER).

Who is sponsoring clinical trial NCT04000971?

This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.